德國專利法院首項裁決出爐,CureVac 提告BioNTech 侵權吃下敗仗| GeneOnline News 基因線上 GeneOnline - 21 Dec 2023 德國專利法院首項裁決出爐,CureVac 提告BioNTech 侵權吃下敗仗| GeneOnline News ... More
聯合防禦COVID-19 與流感病毒!CureVac 跟進公布兩疫苗的一期試驗初步結果| GeneOnline News 基因線上 GeneOnline - 09 Jan 2023 聯合防禦COVID-19 與流感病毒!CureVac 跟進公布兩疫苗的一期試驗初步結果| GeneOnline News ... More
德國實驗室CureVac開發新疫苗效率僅48% 正等歐洲藥管局批准 - RFI 法國國際廣播電台 - 01 Jul 2021 德國實驗室CureVac開發新疫苗效率僅48% 正等歐洲藥管局批准 ... More
蓋茲支持的CureVac疫苗有效度僅47%!盤後股價摔5成 - 新聞 MoneyDJ理財網 - 17 Jun 2021 蓋茲支持的CureVac疫苗有效度僅47%!盤後股價摔5成 - 新聞 ... More
比爾蓋茲投的mRNA疫苗三期試驗失敗!德國CureVac新冠疫苗保護力僅47%意外落馬 Yahoo奇摩新聞 - 17 Jun 2021 比爾蓋茲投的mRNA疫苗三期試驗失敗!德國CureVac新冠疫苗保護力僅47%意外落馬 ... More
CureVac 新冠疫苗期中報告出爐,有效性僅47% 未達標準| GeneOnline News 基因線上 GeneOnline - 17 Jun 2021 CureVac 新冠疫苗期中報告出爐,有效性僅47% 未達標準| GeneOnline News ... More
國產疫苗享用免疫橋接取代三期?看看德國CureVac解盲失敗的慘痛教訓 Yahoo奇摩新聞 - 18 Jun 2021 國產疫苗享用免疫橋接取代三期?看看德國CureVac解盲失敗的慘痛教訓 ... More
CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech CureVac - 19 May 2023 CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech ... More
German Federal Patent Court changes its mind on CureVac mRNA patent JUVE Patent - 19 Dec 2023 German Federal Patent Court changes its mind on CureVac mRNA patent ... More
新冠疫苗产权之争:CureVac将与BioNTech对簿公堂– DW – 2022年7月9日 - DW (中文) 德國之聲 - 09 Jul 2022 新冠疫苗产权之争:CureVac将与BioNTech对簿公堂– DW – 2022年7月9日 ... More
Coronavirus: Commission offers financing to innovative vaccines company CureVac European Union - 16 Mar 2020 Coronavirus: Commission offers financing to innovative vaccines company CureVac ... More
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines MD Anderson Cancer Center - 16 Apr 2024 MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines ... More
CureVac sues BioNTech over mRNA technology Nature - 09 Aug 2022 CureVac sues BioNTech over mRNA technology ... More
CureVac announces positive Phase II Covid-19 vaccine trial data Clinical Trials Arena - 09 Jan 2024 CureVac announces positive Phase II Covid-19 vaccine trial data ... More
Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech JUVE Patent - 17 Aug 2023 Düsseldorf Regional Court waits for validity judgments in CureVac v BioNTech ... More
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma CureVac - 20 Jun 2023 CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma ... More
CureVac files vaccine patent infringement claim against BioNTech in Düsseldorf JUVE Patent - 07 Jul 2022 CureVac files vaccine patent infringement claim against BioNTech in Düsseldorf ... More